To be in line with the national policy, TBSF screened plasma raw materials that were voluntarily donated from eligible nationals. After the raw materials passed virus mark test and highly sensitive nucleic acid amplification testing (NAT), they were entrusted to the Australian-based PIC/S GMP CSL Behring plasma factory, which has been approved by the Food and Drug Administration, Ministry of Health and Welfare for manufacturing four products: ““TBSF” (20%) Human Albumin Solution, “TBSF” Human Immunoglobulin for Intravenous Use, “TBSF” High Purity Factor VIII / Von Willebrand Factor Concentrate, and“TBSF” High Purity Factor IX Concentrate.
From national plasma raw materials to final “TBSF” blood products, the whole process is checked by the Therapeutic Goods Administration (TGA) in Australia and the Food and Drug Administration, Ministry of Health and Welfare (TFDA) to ensure the quality and safety, from plasma raw materials screening to final blood preparation, is in line with international standards so that the rights and interests of domestic patients are ensured.
TDUA was originated by TTLA, TDMDA, TEEIA and SID Taipei Chapter. TDUA is a civil organization which: (1)Consolidates industrial consensus through various activities. (2)Promotes industrial cooperation within competition. (3)Facilitates the integrated growth of the Taiwan FPD industry. (4)Acts as the window for interaction with international organization.